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Background: It is possible that blood B vitamins level and cognitive function may be affected by dietary intake of
these vitamins, no study however has yet been conducted on relationships between B vitamins intake and
cognitive function among elderly population in Korea. This study examined the relationship between B vitamins
intake and cognitive function among elderly in South Korea.
Methods: Participants consisted of 100 adults with mild cognitive impairment (MCI), 100 with Alzheimer’s disease
(AD), and 121 normal subjects. Dietary intake data that included the use of dietary supplements were obtained using a
24-hour recall method by well-trained interviewers. Plasma folate and vitamin B12 concentrations were analyzed by
radioimmunoassay, and homocysteine (Hcy) was assessed by a high performance liquid chromatography-fluorescence
method.
Results: Plasma levels of folate and vitamin B12 were positively correlated with B vitamins intake; and plasma Hcy was
negatively correlated with total intake of vitamin B2, vitamin B6, vitamin B12 and folate. In the AD group, a multiple
regression analysis after adjusting for covariates revealed positive relationships between vitamin B2 intake and test scores
for the MMSE-KC, Boston Naming, Word Fluency, Word List Memory and Constructional Recall Tests; and between vitamin
B6 intake and the MMSE-KC, Boston Naming, Word Fluency, Word List Memory, Word List Recognition, Constructional
Recall and Constructional Praxis Tests. Positive associations were observed between vitamin B12 intake and the MMSE-KC,
Boston Naming, Constructional Recall and Constructional Praxis Tests, and between folate intake and the Constructional
Recall Test. In the MCI group, vitamin B2 intake was positively associated with the MMSE-KC and Boston Naming Test,
vitamin B6 intake was positively associated with the Boston Naming Test, and folate intake was positively associated with
the MMSE-KC and Word List Memory test. No associations were observed in the normal group.
Conclusion: These results suggested that total B vitamins intake is associated with cognitive function in cognitively
impaired AD and MCI elderly, and the association is stronger in AD patients.
Keywords: B vitamins, Total intake, Cognitive function, Mild cognitive impairment, Alzheimer’s diseaseBackground
A decline in cognitive function occurs as a normal part
of the aging process [1]. However, a degree of cognitive
impairment can be influenced by modifiable health
behavior, including diet and nutrition [2]. B vitamins
of folate, vitamin B2, vitamin B6 and vitamin B12 are
involved in one-carbon transfer reactions such as* Correspondence: nschang@ewha.ac.kr
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unless otherwise stated.methylation, which is necessary for the production of
monoamine neurotransmitters, phospholipids and nucleo-
tides [3] in the brain. Low levels of these B vitamins have
been associated with increased homocysteine (Hcy) [4],
known to have a direct neurotoxic effect [5]. Several
cross-sectional [6-9] and longitudinal studies [10-13] have
proposed that elevated Hcy levels may be an independent
risk factor for impaired cognitive function or Alzheimer’s
disease (AD). In an elderly Korean population study,
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impairment (MCI) [14].
As in Western countries [15,16], several studies
conducted in South Korea [17-19] have found relationships
between the level of B vitamins in blood and cognitive
function. In Korean elderly subjects, the serum folate level
shows a significant positive correlation with MMSE-K [19].
The folate level in plasma and red blood cells was signifi-
cantly correlated with test scores for several domains of
cognitive function. Vitamin B1, vitamin B2, and vitamin B6
were positively correlated with neuropsychological function
test scores, although not as strongly as folate [18].
Our previous study [20] showed that plasma folate,
vitamin B12, and Hcy are associated with cognitive function
in cognitively impaired (AD and MCI) elderly, and
the association was stronger in patients with AD. A
study in Australia investigated the relationship of serum B
vitamins level and cognitive function, according to the
degree of cognitive damage in AD, MCI and normal
subjects [21]. However, these studies [20,21] did not
contain dietary information.
The level of B vitamins in blood, especially folate, is
affected by dietary intake [22,23]. Prospective [24]
and case–control studies [25,26] have shown that low
dietary intake of B vitamins was associated with cognitive
decline [24] or an increased risk of AD [25,26]. However,
null findings have been reported [27]. There is little or no
data on the relationship between B vitamins intake and
cognitive function among elderly population in Korea,
where a folic acid fortification policy is not yet mandated.
South Korea has one of the most rapidly aging popula-
tions in the world [28]. According to a 2012 Ministry of
Health and Welfare report [29], it is estimated that 9.2%
of elderly aged ≥ 65 years have dementia and 27.8% have
MCI. Given that the proportion of elderly with MCI and
dementia in South Korea has drastically increased,
more research on the correlation between B vitamins
and cognitive function is needed.
This study investigated the relationship between B
vitamins intake and cognitive function among normal,
MCI, and AD groups in Korean elderly over 60 years
of age.
Methods
Study participants and data collection
Study subjects aged ≥ 60 years were recruited from April
2010 to June 2011 in the Songpa district, one of 25
districts in Seoul, South Korea. All participants completed
the Korean version of the Consortium to Establish a
Registry for Alzheimer’s Disease (CERAD-K) assessment
packet, which consists of a neuropsychological and clinical
assessment battery. A total of 321 subjects, including 121
normal subjects (37.7%), 100 MCI patients (31.2%) and
100 AD patients (31.2%) were included in the final analysis.Comprehensive information is available in a previous study
[20]. All subjects were interviewed by trained interviewers
with caregivers present. The questionnaire was designed to
obtain information on general characteristics, including
age, gender, education, marital status, smoking status, and
alcohol use. Disease prevalence was also investigated for
vascular risk factors, including hypertension, diabetes
mellitus, dyslipidemia, stroke, cardiovascular disease,
and thyroid disease. Height and weight were measured,
and body mass index (BMI) (kg/m2) was calculated as
weight in kilograms divided by the square of the height in
meters (kg/m2).
Dietary assessment
Dietary data were collected with a 24-hour recall for
intake on the day before blood sampling. Experienced,
well-trained dietary interviewers instructed respondents to
describe all foods and beverages consumed over the past
24 hours. The most frequently eaten food items were set
as models in a defined unit and shown to subjects to
increase the accuracy of reporting. Household portions in
each subject’s record were converted to mass weight (in
grams). Dietary intake data were analyzed using the
computer-aided nutritional analysis program software
(CAN-Pro version 3.0; Nutritional Assessment Program,
2006, The Korean Nutrition Society, Seoul, Korea).
Evidence-based vitamin B12 values from a book of Food
Values [30] and a study in South Korea [31] were added to
the Can-Pro 3.0 database.
Information on brand names and consumption frequency
was collected from subjects ingesting dietary supplements.
Daily nutrient intake from dietary supplements was calcu-
lated using frequency and nutrient content of supplements.
Dietary folate equivalent (DFE) was calculated based on
1.0 mg DFE = 1.0 mg of food folate or 0.6 mg of folic acid
added to food [32]. Folate and other B vitamins intake data,
including supplements, were compared with estimated
average requirements (EARs) of Korean Dietary Reference
Intakes (KDRI) [33].
Statistical analysis
Data are expressed as means with standard deviation.
Values for plasma folate, vitamin B12 and Hcy, and
nutrient intake, were log-transformed to satisfy assumptions
of normality. To examine differences in nutrient intake
among the three groups, a general linear model (GLM)
procedure was performed after adjusting for age, gender,
BMI, marital status, education, current smoking, energy
intake, thyroid disease, and vascular risk factors such as
hypertension, diabetes mellitus, dyslipidemia, stroke and
cardiovascular disease. Possible confounding factors were
considered on the association between B vitamins intake
and cognitive function; Variables 1) which were significantly
different among diagnostic groups, and previously reported
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status, education and current smoking), 2) which had
no significant difference among diagnostic groups in
the present study, nevertheless, previous studies reported to
have a relationship with AD {thyroid disease and vascular
risk factors (whether or not a given subject had 1 ≥ of
diseases, including hypertension, diabetes mellitus,
dyslipidemia, stroke and cardiovascular disease)}, and
3) which affect nutrient intake from diet {BMI, energy
intake (ln)} were adjusted as covariates. Pearson’s
correlation test was used to analyze correlations between
nutrient intake and plasma folate, vitamin B12 and Hcy
levels by group. Multiple linear regression analyses were
used to examine the relationship between nutrient intake
and cognitive function scores by group after adjusting for
confounders. A two-tailed p-value < 0.05 was considered
significant. Statistical analyses were performed using SAS
software version 9.3 (SAS Institute, Cary, NC, USA).
Results
General characteristics and nutrient intakes
The general characteristics of participants are described
in a previous study [20]. The mean age of subjects was
74.8 ± 7.2 years, and patients with AD were older than
those without AD. Patients with AD were less educated,




(n = 100) (n
Energy (kcal)
Diet only 1487.3 ± 445.3 1450.4 ± 449.5 1447
Total 1490.4 ± 445.51 1451 ± 449.6 1450
Protein (g/d)
Diet only 56.0 ± 22.6 54.9 ± 23.7 53
Total 56.0 ± 22.6 54.9 ± 23.7 53
Vitamin B2 (mg/d)
Diet only 0.9 ± 0 .4 0.8 ± 0.4 0
Total 2.3 1.8 ± 2.9 2
Vitamin B6 (mg/d)
Diet only 1.6 ± 0.7 1.5 ± 0.7 1
Total 3.3 ± 6.6 2.4 ± 2.4 3
Vitamin B12 (μg/d)
Diet only 5.7 ± 7.1 5.4 ± 6.7 5
Total 8.2 ± 14.1 6.7 ± 9.8 7
Folate (μg DFE/d)
Diet only 437.6 ± 209.8 402.3 ± 215.5 418
Total 469.7 ± 227.1 432.9 ± 232.2 455
1Values are mean ± SD.
2Analyzed by ANOVA after log transformed.
3Analyzed by GLM at p < 0.05 after log transformed, adjusted for age, sex, BMI, mar
vascular risk factors (hypertension, diabetes mellitus, dyslipidemia, stroke and cardioproportion of females than those without AD. The average
dietary and total nutrient intake including supplements is
presented in Table 1. The total energy intake of subjects
was 1490.4 ± 445.5 kcal, which was 75.1% less than the
estimated energy requirement (EER) for KDRI. Mean
intake of total energy, protein and folic acid was signifi-
cantly lower in MCI and AD groups compared to the nor-
mal group. However, no significant difference in nutrient
intake was found among all groups after adjustment for
covariates of age, gender, BMI, marital status, education,
current smoking, energy intake, thyroid disease, and
vascular risk factors, such as hypertension, diabetes
mellitus, dyslipidemia, stroke and cardiovascular disease.
Correlation between B vitamins intake and plasma
concentrations of folate, vitamin B12, and Hcy
The plasma levels of folate, vitamin B12, and Hcy are
reported in our previous study [20].
For total (all) subjects, after adjustment for covariates,
plasma folate was positively correlated with total intake of
protein (r = 0.141, p-value < 0.05), vitamin B2 (r = 0.276,
p-value < 0.001), vitamin B6 (r = 0.279, p-value < 0.001)
and folic acid (r = 0.339, p-value < 0.001). Plasma vitamin
B12 was positively correlated with total vitamin B2
intake (r = 0.129, p-value < 0.05). Plasma Hcy was







.4 ± 477.7 1550.9 ± 408.9 0.045 0.161
.6 ± 477.6 1555.8 ± 409.1 0.040 0.170
.4 ± 23.3 59.1 ± 20.9 0.022 0.460
.4 ± 23.3 59.1 ± 20.9 0.022 0.558
.8 ± 0.4 0.9 ± 0.4 0.007 0.360
.7 ± 6.2 2.4 ± 5.3 0.410 0.597
.5 ± 0.7 1.7 ± 0.6 0.008 0.442
.8 ± 7.9 3.6 ± 7.7 0.358 0.432
.5 ± 7.1 6.1 ± 7.4 0.170 0.586
.5 ± 9.9 10.0 ± 19.0 0.185 0.608
.7 ± 204.4 482.5 ± 203.2 0.002 0.316
.7 ± 220.4 511.6 ± 223.5 0.006 0.499
ital status, education, current smoking, energy intake(ln), thyroid disease and
vascular disease) as covariates.
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p-value < 0.01), vitamin B12 (r = −0.127, p-value < 0.05)
and folic acid (r = −0.151, p-value < 0.01).
In the AD group, plasma folate was positively correlated
with total folic acid intake only, and Hcy was negatively cor-
related with total vitamin B6 intake. No significant correl-
ation was found between plasma vitamin B12 and intake of
any B vitamins. In the MCI group, plasma folate was posi-
tively correlated with total intake of protein, vitamin B2,
vitamin B6 and folic acid, similar to results for total subjects.
Plasma vitamin B12 was positively correlated with total folic
acid intake, and Hcy was negatively correlated with total
vitamin B2 intake. In the normal group, plasma folate and
vitamin B12 were positively correlated with total intake of
protein, vitamin B2, vitamin B6 and folic acid, similar to
results for total subjects. However, there was no correlation
between plasma Hcy and B vitamins intake (Table 2).
Association between B vitamins intake and cognitive
function
In total subjects, dietary vitamin B2 intake was positively
associated with the Constructional Recall Test scores,Table 2 Correlation coefficients between B vitamins
intake and plasma homocysteine levels according to AD,











Diet only −0.040 0.126 0.166 −0.072
Total −0.040 −0.113 0.062 −0.084
Protein (g/d)
Diet only −0.012 0.125 −0.063 0.010
Total −0.065 0.125 −0.063 0.010
Vitamin B2 (mg/d)
Diet only −0.172** 0.069 −0.204 0.053
Total −0.185*** −0.182 −0.208* −0.133
Vitamin B6 (mg/d)
Diet only −0.168** 0.075 0.098 0.015
Total −0.183** −0.216* −0.130 −0.141
Vitamin B12 (μg/d)
Diet only −0.115* −0.111 −0.053 −0.019
Total −0.127* −0.173 0.069 −0.143
Folate (μg DFE/d)
Diet only −0.036 −0.093 0.102 −0.031
Total −0.151** −0.121 −0.104 −0.063
Data on intake and plasma level are log transformed. Adjusted for age, sex,
BMI, marital status, education, current smoking, energy intake(ln), thyroid
disease and vascular risk factors (hypertension, diabetes mellitus, dyslipidemia,
stroke and cardiovascular disease) as covariates (*p < 0.05,
**p < 0.01, ***p < 0.001).and dietary vitamin B6 intake was associated with the
Boston Naming Test and Word List Memory Test scores.
Folate intake was positively associated with the Word
List Memory Test and Constructional Recall Test scores
(Table 3).
In AD subjects, no association was observed between
cognitive function scores and any dietary parameters. In
MCI subjects, dietary vitamin B2 intake was positively
associated with the Word List Memory, Word List
Recognition and Constructional Recall Test scores;
and dietary folate intake was positively associated with
the Word List Memory and Word List Recognition
Test scores. In normal subjects, dietary vitamin B6 intake
was positively associated with the Word List Memory
Test scores.
The association between total B vitamins intake and
cognitive function scores in each group is presented in
Table 4. In total subjects, total vitamin B2 intake was
positively associated with the MMSE-KC and Boston
Naming Test scores, and total vitamin B6 intake was
associated with the Boston Naming Test scores. Folic
acid intake was positively associated with the MMSE-KC,
Word List Memory Test and Constructional Recall Test
scores. In AD subjects, total vitamin B2 intake was
positively associated with the MMSE-KC, Boston
Naming Test, Word Fluency, Word List Memory Test
and Constructional Recall Test scores; and total vitamin
B6 intake was positively associated with the MMSE-KC,
Boston Naming Test, Word Fluency, Word List Memory,
Word List Recognition Test, Constructional Recall Test
and Constructional Praxis Test scores. Total vitamin B12
intake was positively associated with the MMSE-KC,
Boston Naming Test, Constructional Recall Test and
Constructional Praxis Test scores; and total folic acid
intake was positively associated with the Constructional
Recall Test scores. In MCI subjects, total vitamin B2
intake was positively associated with the MMSE-KC and
Boston Naming Test scores; and total vitamin B6 intake
was positively associated with the Boston Naming Test
scores. Total folic acid intake was positively associated
with the MMSE-KC and Word List Memory Test scores.
No association was observed between cognitive function
scores and any dietary parameters in the normal group.
When we additionally adjusted for intakes of antioxidant
nutrient such as vitamin C, vitamin E and β-carotene,
the positive association between B vitamins intake and
cognitive function still existed. A stronger association was
shown in patients with AD compared to normal and
MCI subjects. This suggests that the positive association
between B vitamins intake and cognitive function in
our study was not likely due to an increased B vitamins
intake in these elderly whose antioxidant nutrient
consumption was high compared with their counterparts
(data not shown).
Table 3 Coefficients from multiple regression analysis between dietary B vitamins intake and neuropsychological test scores according to AD, MCI and normal
groups
Dietary Intakes MMSE-KC Boston naming test Verbal fluency Word list memory Word list recall Word list recognition Constructional recall Constructional praxis
All (n = 321) 20.6 ± 5.9 8.4 ± 3.5 9.4 ± 4.7 11.5 ± 5.5 3.1 ± 2.5 6.5 ± 3.0 3.7 ± 3.2 7.9 ± 2.7
Vitamin B2 (mg/d) β (SE) 0.816 (0.702) 0.256 (0.451) 0.577 (0.645) 1.218 (0.670) 0.175 (0.332) 0.434 (0.428) 1.066 (0.419) 0.373 (0.341)
p- value 0.246 0.571 0.371 0.070 0.599 0.312 0.012 0.275
Vitamin B6 (mg/d) β (SE) 0.321 (0.799) 1.039 (0.510) 0.443 (0.734) 1.581 (0.760) 0.330 (0.378) 0.666 (0.486) 0.737 (0.480) −0.059 (0.388)
p-value 0.688 0.043 0.547 0.038 0.382 0.172 0.126 0.879
Vitamin B12 (μg/d) β (SE) 0.177 (0.184) 0.023 (0.117) 0.045 (0.169) 0.293 (0.174) 0.043 (0.087) 0.082 (0.112) 0.094 (0.111) 0.121 (0.090)
p-value 0.338 0.841 0.792 0.093 0.620 0.467 0.398 0.179
Folate (μg DFE/d) β (SE) 0.953 (0.577) 0.157 (0.372) 0.249 (0.533) 1.095 (0.552) 0.263 (0.274) 0.395 (0.353) 0.848 (0.346) −0.136 (0.282)
p-value 0.100 0.674 0.641 0.048 0.338 0.264 0.015 0.630
AD (n = 100)
Vitamin B2 (mg/d) β (SE) −0.734 (1.078) 0.185 (0.875) 0.406 (1.030) −0.876 (1.046) −0.015 (0.380) −0.660 (0.897) 0.188 (0.438) 0.086 (0.717)
p-value 0.498 0.833 0.694 0.405 0.969 0.464 0.669 0.905
Vitamin B6 (mg/d) β (SE) 0.427 (1.109) 0.863 (0.894) 0.900 (1.054) 0.638 (1.077) 0.415 (0.387) 0.292 (0.924) 0.472 (0.447) 0.597 (0.733)
p-value 0.701 0.337 0.395 0.555 0.287 0.753 0.294 0.418
Vitamin B12 (μg/d) β (SE) 0.481 (0.268) 0.269 (0.216) 0.285 (0.261) 0.375 (0.261) 0.063 (0.087) 0.086 (0.226) 0.162 (0.107) 0.325 (0.180)
p-value 0.077 0.216 0.278 0.154 0.472 0.705 0.135 0.075
Folate (μg DFE/d) β (SE) −0.457 (0.829) −0.689 (0.669) 0.168 (0.792) −0.368 (0.807) 0.237 (0.291) −0.547 (0.689) 0.394 (0.334) −0.814 (0.544)
p-value 0.583 0.306 0.832 0.649 0.417 0.430 0.242 0.138
MCI (n = 100)
Vitamin B2 (mg/d) β (SE) 1.705 (1.089) 0.517 (0.762) 1.082 (1.027) 2.293 (1.145) 0.704 (0.575) 1.461 (0.682) 1.380 (0.684) 1.133 (0.587)
p-value 0.121 0.499 0.295 0.048 0.224 0.035 0.047 0.057
Vitamin B6 (mg/d) β (SE) −0.006 (1.251) 0.583 (0.863) −0.779 (1.168) 0.781 (1.323) 0.172 (0.657) 1.083 (0.784) 1.205 (0.782) −0.454 (0.677)
p-value 0.996 0.502 0.506 0.557 0.794 0.171 0.127 0.504
Vitamin B12 (μg/d) β (SE) −0.310 (0.261) −0.236 (0.187) 0.139 (0.252) 0.078 (0.269) −0.055 (0.139) 0.168 (0.168) −0.026 (0.172) −0.094 (0.148)
p-value 0.238 0.209 0.582 0.772 0.691 0.319 0.879 0.529
Folate (μg DFE/d) β (SE) 1.817 (0.933) 0.193 (0.659) 0.868 (0.887) 2.137 (0.984) 0.662 (0.495) 1.388 (0.586) 1.022 (0.594) 0.092 (0.517)
p-value 0.055 0.770 0.330 0.033 0.185 0.020 0.089 0.859
Normal (n = 121)
Vitamin B2 (mg/d) β (SE) 0.020 (0.904) −0.730 (0.699) −0.551 (1.133) 1.215 (1.077) −0.436 (0.573) 0.339 (0.554) 0.532 (0.807) −0.100 (0.517)
p-value2) 0.983 0.298 0.628 0.262 0.448 0.541 0.511 0.847
Vitamin B6 (mg/d) β (SE) −0.460 (1.032) 1.434 (0.791) 0.544 (1.295) 2.484 (1.215) 0.047 (0.656) 0.627 (0.631) −0.789 (0.921) −0.474 (0.589)















Table 3 Coefficients from multiple regression analysis between dietary B vitamins intake and neuropsychological test scores according to AD, MCI and normal
groups (Continued)
Vitamin B12 (μg/d) β (SE) 0.139 (0.259) −0.083 (0.194) −0.620 (0.316) 0.212 (0.309) 0.063 (0.163) −0.146 (0.156) 0.038 (0.230) 0.213 (0.145)
p-value 0.593 0.670 0.052 0.495 0.700 0.351 0.870 0.146
Folate (μg DFE/d) β (SE) 0.480 (0.741) 0.074 (0.576) −1.373 (0.922) 0.630 (0.887) −0.550 (0.468) −0.230 (0.455) 0.067 (0.664) 0.262 (0.424)
p-value 0.518 0.898 0.139 0.479 0.242 0.615 0.920 0.538
Data on intake and plasma level are log transformed. Adjusted for age, gender, BMI, marital status, education, current smoking, energy intake (ln), thyroid disease and vascular risk factors (hypertension, diabetes















Table 4 Coefficients from multiple regression analysis between total B vitamins intake and neuropsychological test scores according to AD, MCI and normal
groups
Total Intakes MMSE-KC Boston naming test Verbal fluency Word list memory Word list recall Word list recognition Constructional recall Constructional praxis
All (n = 321) 20.6 ± 5.9 8.4 ± 3.5 9.4 ± 4.7 11.5 ± 5.5 3.1 ± 2.5 6.5 ± 3.0 3.7 ± 3.2 7.9 ± 2.7
Vitamin B2 (mg/d) β (SE) 0.581 (0.265) 0.376 (0.170) 0.182 (0.245) 0.284 (0.255) −0.055 (0.126) 0.192 (0.162) 0.079 (0.161) 0.190 (0.129)
p- value 0.029 0.028 0.458 0.266 0.664 0.237 0.625 0.143
Vitamin B6 (mg/d) β (SE) 0.609 (0.323) 0.647 (0.205) 0.317 (0.298) 0.395 (0.310) −0.067 (0.153) 0.294 (0.197) 0.008 (0.196) 0.202 (0.157)
p-value 0.060 0.002 0.288 0.204 0.664 0.137 0.969 0.201
Vitamin B12 (μg/d) β (SE) 0.288 (0.173) 0.160 (0.111) 0.131 (0.159) 0.306 (0.164) 0.002 (0.082) 0.073 (0.106) 0.089 (0.105) 0.163 (0.085)
p-value 0.098 0.150 0.413 0.063 0.979 0.490 0.397 0.055
Folate (μg DFE/d) β (SE) 1.358 (0.553) 0.573 (0.357) 0.574 (0.512) 1.165 (0.530) 0.211 (0.264) 0.412 (0.339) 0.768 (0.333) 0.047 (0.271)
p-value 0.015 0.110 0.263 0.029 0.425 0.226 0.022 0.863
AD (n = 100)
Vitamin B2 (mg/d) β (SE) 1.040 (0.426) 0.783 (0.347) 0.835 (0.411) 0.882 (0.418) 0.089 (0.154) 0.683 (0.360) 0.436 (0.172) 0.391 (0.289)
p-value 0.017 0.027 0.045 0.038 0.566 0.061 0.013 0.180
Vitamin B6 (mg/d) β (SE) 1.476 (0.526) 1.213 (0.425) 1.393 (0.502) 1.521 (0.508) 0.251 (0.191) 1.113 (0.441) 0.652 (0.211) 0.734 (0.356)
p-value 0.006 0.005 0.007 0.004 0.191 0.014 0.003 0.042
Vitamin B12 (μg/d) β (SE) 0.656 (0.247) 0.448 (0.200) 0.417 (0.244) 0.487 (0.245) 0.003 (0.092) 0.138 (0.215) 0.252 (0.099) 0.425 (0.167)
p-value 0.010 0.028 0.090 0.050 0.978 0.524 0.012 0.013
Folate (μg DFE/d) β (SE) 0.619 (0.765) 0.059 (0.622) 0.946 (0.725) 0.378 (0.745) 0.203 (0.269) 0.129 (0.639) 0.683 (0.303) −0.226 (0.509)
p-value 0.420 0.925 0.196 0.614 0.452 0.840 0.027 0.657
MCI (n = 100)
Vitamin B2 (mg/d) β (SE) 0.666 (0.400) 0.561 (0.275) 0.699 (0.373) 0.519 (0.428) 0.106 (0.213) 0.159 (0.257) 0.043 (0.258) 0.214 (0.220)
p-value 0.010 0.045 0.065 0.229 0.620 0.537 0.870 0.334
Vitamin B6 (mg/d) β (SE) 0.761 (0.497) 1.008 (0.331) 0.569 (0.467) 0.332 (0.532) −0.014 (0.264) 0.258 (0.318) −0.067 (0.319) 0.080 (0.273)
p-value 0.129 0.003 0.227 0.534 0.959 0.420 0.835 0.769
Vitamin B12 (μg/d) β (SE) −0.187 (0.265) −0.035 (0.191) 0.398 (0.252) 0.191 (0.272) −0.080 (0.140) 0.106 (0.171) −0.107 (0.173) −0.119 (0.150)
p-value 0.482 0.855 0.117 0.485 0.569 0.535 0.538 0.430
Folate (μg DFE/d) β (SE) 2.155 (0.920) 0.951 (0.648) 1.330 (0.876) 2.231 (0.977) 0.577 (0.494) 0.936 (0.592) 0.780 (0.595) −0.040 (0.515)
p-value 0.021 0.146 0.132 0.025 0.246 0.118 0.193 0.938
Normal (n = 121)
Vitamin B2 (mg/d) β (SE) 0.358 (0.320) −0.076 (0.250) −0.436 (0.401) −0.195 (0.385) −0.147 (0.204) −0.073 (0.197) −0.158 (0.287) 0.225 (0.183)
p-value2) 0.266 0.761 0.279 0.613 0.472 0.710 0.584 0.220
Vitamin B6 (mg/d) β (SE) 0.151 (0.373) 0.057 (0.290) −0.230 (0.467) −0.040 (0.446) −0.121 (0.236) −0.047 (0.228) −0.366 (0.332) 0.180 (0.213)















Table 4 Coefficients from multiple regression analysis between total B vitamins intake and neuropsychological test scores according to AD, MCI and normal
groups (Continued)
Vitamin B12 (μg/d) β (SE) 0.115 (0.224) −0.093 (0.168) −0.273 (0.270) −0.020 (0.268) −0.008 (0.141) −0.154 (0.134) −0.027 (0.199) 0.246 (0.125)
p-value 0.609 0.579 0.054 0.942 0.957 0.254 0.892 0.051
Folate (μg DFE/d) β (SE) 0.455 (0.585) 0.042 (0.561) −1.425 (0.895) 0.348 (0.864) −0.358 (0.457) −0.313 (0.441) 0.057 (0.646) 0.470 (0.410)
p-value 0.438 0.941 0.114 0.688 0.435 0.479 0.930 0.255
Data on intake are log transformed. Adjusted for age, gender, BMI, marital status, education, current smoking, energy intake (ln), thyroid disease and vascular risk factors (hypertension, diabetes mellitus, dyslipidemia,
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Dietary and total B vitamins intake was negatively
correlated with plasma Hcy levels and positively associated
with cognitive function scores, with different associations
according to cognitive status. Positive associations between
total B vitamins intake and cognitive function were
observed for vitamin B2, vitamin B6, vitamin B12 and
folic acid in the AD group, and for vitamin B2, vitamin B6
and folate in the MCI group. No association was observed
between vitamin B intake and cognitive function in the
normal group. Results are similar to our previous finding
[20] that plasma folate, vitamin B12, and Hcy are associated
with cognitive function in cognitively impaired (AD and
MCI) elderly. A stronger association was shown in patients
with AD compared to normal and MCI subjects and
cannot be explained. Results indicated that plasma
folate and vitamin B12 were associated with Hcy and
cognitive function as reported by previous studies
[7,9,15,20], and dietary intake of Hcy-lowering vitamins
of vitamin B2, vitamin B6, vitamin B12 and folate was
also related.
A negative correlation between plasma Hcy and B
vitamins intake among elderly is supported by previous
reports [34,35]. As vitamin B2, vitamin B6, vitamin
B12 and folate are metabolically interrelated in one-carbon
metabolism, it is not surprising that the intake of vitamin
B2, vitamin B6, vitamin B12 and folate is inversely related
to plasma Hcy. Hcy is a byproduct of a sulfur-containing
amino acid methionine, which is formed from the universal
methyl donor SAM during methylation of biomolecules
and hydrolysis of S-adenosylhomocysteine to Hcy. The
resulting Hcy is remethylated to methionine by methylene-
tetrahydrofolate, generated in the one-carbon metabolism
cycle where Hcy-lowering B vitamins are metabolically
interrelated [36].
Plasma Hcy level was differed significantly among
diagnostic groups; however, no differences in dietary
intake of vitamin B2, vitamin B6, vitamin B12 and
folate were observed among three groups. A U.K.
study reported that the mean intake of folate, vitamin
B6, and B12 did not differ significantly between normal
and AD patients, but plasma Hcy levels were influenced by
intake of these vitamins [37]. The Baltimore Longitudinal
Study of Aging reported that folate intake at or above the
recommended dietary allowance (RDA) is associated with
a reduced risk of AD, but no association was found
to vitamin B6 and B12 intake [26]. Other prospective
studies found no relationship between the intake of
other B vitamins and AD risk [27,38].
Cognitive function test scores were positively asso-
ciated with intake of vitamin B2, vitamin B6, vitamin
B12 and folate in the AD group; vitamin B2, vitamin
B6 and folate in the MCI group; and none in the
normal group.To the best of our knowledge, no study had previously
investigated an association between B vitamins intake and
cognitive function in AD patients. Intervention studies
reported that B vitamins supplementation {Folic acid
(5 mg/day) and B12 (1 mg/day)} could improve cognitive
performance, but only in mild to moderately demented
AD patients with elevated Hcy levels at the baseline
[39,40]. Aisen et al. [41] reported that in mild AD treat-
ment with high-dose B vitamins supplements {Folic acid
(5 mg/day), B6 (25 mg/day) and B12 (1 mg/day)} did slow
cognitive decline, whereas in moderate AD it did not.
In the MCI group, intake of vitamin B2, vitamin B6
and folate was positively associated with cognitive
function test scores. There have been no reports on
the relationship between B vitamins intake and cognitive
function in MCI patients. However, a study in Korea inves-
tigating associations with serum vitamin levels and cogni-
tive function found a relationship between serum folate
level and MMSE-K scores [19]. An intervention study on
MCI subjects reported that B vitamins supplementation
{folic acid (0.8 mg/day), B12 (0.5 mg/day), B6 (20 mg/day)}
stabilized the executive function and improved global
cognition, episodic and semantic memory, and global
clinical dementia rating scores in patients with elevated
baseline Hcy levels [42]. In contrast, another study found
that supplementation did not improve cognitive function
[43]. These negative results could be explained that the
subjects were not stratified for baseline homocysteine.
In the normal group, no association was observed
between B vitamins intake and cognitive function
scores. This is in line with conflicting results of previous
studies. A UK study [27] reported no association between
B vitamins intake and cognitive function scores in normal
elderly patients. In Korea, two studies reported a positive
relationship between vitamin B2 intake and cognitive
function scores including MMSE-K in normal Korean
elderly subjects [44,45]. Studies demonstrated that
supplementation with folic acid, B12, and B6 improved
cognitive function such as immediate and delayed memory,
information processing speed, and sensorimotor speed
[46-48]; and vitamin B12 supplementation in elderly with
cobalamin deficiency resulted in reduced motor function
scores [49].
Results of this study showed that vitamin B6 intake was
associated with the greatest number of cognitive function
indicators. Daily intake of vitamin B6 was 1.6 ± 0.7 mg,
and 33% of subjects consumed less than EAR for KDRI
(data not shown). Seo et al. [50] reported that the average
daily intake of vitamin B6 in Korean elderly residing in
rural areas was 1.1 ± 0.7 mg (80.1% of RNI, Recommended
Nutrient Intake), lower than our study. Chang et al. [51]
reported that more than 70% of elderly people in rural
Korea had inadequate functional vitamin B6 status, as
measured by erythrocyte aspartate transaminase activity
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nutritional status in folate, vitamin B12, and vitamin B6
among Korean elderly must be considered, including
the promotion of consuming a diet rich in folate and
B vitamins.
This study had potential limitations, in addition to
those presented in our previous study. First, our study
was observational in nature and cannot prove causality.
Although we attempted to control for the effects of the
major identified predictors of cognitive function, B vitamins
consumption could be a marker for unrecognised factors
that affect cognitive function. Second, results may be
difficult to interpret and apply to the general population, as
a random sample was not utilized. Third, holotranscobala-
mine, a better indicator of vitamin B12 status, was not
measured; and serum vitamin B2 and B6 levels were not
measured, only data on dietary intake. Despite limitations,
and to the best of our knowledge, this is the first study
investigating the relationship between cognitive function
scores and dietary intake by cognitive status.
Conclusion
An association between B vitamins intake and cognitive
function was stronger in cognitively impaired AD and
MCI patients than in normal elderly in Korea. Further
prospective studies are warranted to investigate causal
relationships of cognitive function with nutritional status,
including B vitamins intake.
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